Skip to main content

Advertisement

SpringerLink
Log in

Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-γ production of lymphocytes

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The authors examined interleukin-2 (IL-2) production and interferon γ (IFNγ) production of peripheral blood mononuclear cells in 28 patients with renal cell carcinoma and 17 control subjects. The peripheral blood was obtained prior to the initiation of therapeutic procedures. The patients were divided into two groups according to tumor size, ⩽5 cm and >5 cm. The production of IL-2 and IFNγ was measured by immunoradiometric assay. As a result, in the patients with tumors >5 cm, IL-2 and IFNγ production was impaired. However, in the patients with tumors ⩽5 cm, IFNγ production was enhanced, though IL-2 production was not significantly different from that of the control subjects. There was no significant correlation between IL-2 production and IFNγ production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Catalona WJ, Tarpley JL, Chretien PB (1974) Lymphocyte stimulation in urologic cancer patients. J Urol 112: 373

    PubMed  Google Scholar 

  2. Cole AT, Avis L. Fried FA, Avis F (1976) Cell-mediated immunity in renal cell carcinoma — a preliminary report. J Urol 115: 234

    PubMed  Google Scholar 

  3. Dennert G (1979) Cytolytic and proliferative activity of a permanent T killer cell line. Nature 277: 476

    PubMed  Google Scholar 

  4. Domzig W, Stadler BM, Herberman RB (1983) Interleukin-2 dependence of human natural killer (NK) cell activity. J Immunol 130: 1970

    PubMed  Google Scholar 

  5. Elhilali MM, Nayak SK (1976) In vitro cytotoxicity studies in bladder and renal cancer. Urology 7: 488

    PubMed  Google Scholar 

  6. Fairlamb DJ (1981) Spontaneous regression of metastasis of renal cancer. Cancer 47: 2102

    PubMed  Google Scholar 

  7. Grimm EA, Mazumder A, Shang H, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823

    PubMed  Google Scholar 

  8. Hakala TR, Castro AE, Elliott AY, Fraley EE (1974) Humoral cytotoxicity in human renal cell carcinoma. Invest Urol 11: 405

    PubMed  Google Scholar 

  9. Handa K, Suzuki R, Matsui H (1983) Natural killer (NK) cells as a responder to interleukin 2 (IL-2): II. Il-2 induced interferon γ production. J Immunol 130: 988

    PubMed  Google Scholar 

  10. Havell EA, Spitalny GL, Patel PJ (1982) Enhanced production of murine interferon by T cells generated in response to bacterial infection. J Exp Med 156: 112

    PubMed  Google Scholar 

  11. Hrushesky WJ, Murphy GP (1977) Current status of the therapy of advanced renal cell carcinoma. J Surg Oncol 9: 277

    PubMed  Google Scholar 

  12. Hsia J, Goldstein AL, Simon GL, Sztein M, Hayden FG (1990) Peripheral blood mononuclear cell interleukin 2 and interferon γ production, cytotoxicity and antigen-stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis 162: 591

    PubMed  Google Scholar 

  13. Ikemoto S, Kishimoto T, Wada S, Nishio S, Maekawa M (1990) Clinical studies on cell-mediated immunity in patients with urinary bladder carcinoma. Br J Urol 65: 333

    PubMed  Google Scholar 

  14. Johnson HM (1987) Interferon-mediated modulation of the immune system. In: Pfeffer LM (ed) Mechanisms of interferon actions, vol II. CRC, Boca Raton, Fla., p 61

    Google Scholar 

  15. Katz SE, Schapira HE (1982) Spontaneous regression of genitourinary cancer — update. J Urol 128: 1

    PubMed  Google Scholar 

  16. Kawase I, Brooke CG, Kuribayashi K (1983) Interleukin 2 induces γ-interferon production: participation of macrophages and NK-like cells. J Immunol 131: 288

    PubMed  Google Scholar 

  17. Kusugami K, Morise K, Kato H (1984) Gamma interferon production by peripheral blood lymphocytes in patients with gastric cancer. Nagoya J Med Sci 46: 117

    PubMed  Google Scholar 

  18. McCune CS, Schapira DV, Henshaw EC (1981) Specific immunotherapy of advanced renal carcinoma: evidence for the polyclonality of metastases. Cancer 47: 1984

    PubMed  Google Scholar 

  19. McDonald MW (1982) Current therapy for renal cell carcinoma. J Urol 127: 211

    PubMed  Google Scholar 

  20. McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126: 17

    PubMed  Google Scholar 

  21. Monson JRT, Ramsden C, Guillou PJ (1986) Decreased interleukin 2 production in patients with gastrointestinal cancer. Br J Surg 73: 483

    PubMed  Google Scholar 

  22. Montie JE, Stratton RA, Deodhar SJ, Barna B (1976) In vitro assessment of cell mediated immunity in patients with renal cell cancer. J Urol 115: 239

    PubMed  Google Scholar 

  23. Morales A, Eidinger D (1976) Immune reactivity in renal cancer: a sequential study. J Urol 115: 510

    PubMed  Google Scholar 

  24. Morales A, Wilson JL, Pater JL, Loeb M (1982) Cytoreductive surgery and systemic bacillus Calmette-Guérin therapy in metastatic renal cancer: a phase II trial. J Urol 127: 230

    PubMed  Google Scholar 

  25. Muraki J, Fisher J, Addonizio J, Nagamatsu G, Chiao JW (1989) Immunosuppressive factor derived from renal cancer cells. Urology 34: 205

    PubMed  Google Scholar 

  26. Neidhart JA (1986) Interferon therapy for the treatment of renal cancer. Cancer 57: 1696

    PubMed  Google Scholar 

  27. Neidhart JA, Murphy SG, Hennick LA, Wise HA (1980) Active specific immunotherapy of stage IV renal carcinoma with aggregated tumor antigen adjuvant. Cancer 46: 1128

    PubMed  Google Scholar 

  28. Ritchie AWS, James K, Micklem HS (1984) Lymphocyte subsets in renal carcinoma — a sequential study using monoclonal antibodies. Br J Urol 56: 140

    PubMed  Google Scholar 

  29. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokineactivated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316: 889

    PubMed  Google Scholar 

  30. Tykkä H (1981) Active specific immunotherapy with supportive measures in the treatment of advanced palliatively nephrectomised renal adenocarcinoma. A controlled clinical study. Scand J Urol Nephrol [Suppl] 63: 1

    Google Scholar 

  31. Umeda T, Niijima T (1986) Phase II study of alpha interferon on renal cell carcinoma. Cancer 58: 1231

    PubMed  Google Scholar 

  32. Wanebo H, Pace R, Hargett S, Katz D, Sando J (1986) Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer 57: 656

    PubMed  Google Scholar 

  33. Wright GL Jr, Schellhammer PR, Roasato F, Fauconer RJ (1978) Cell-mediated immunity in patients with renal carcinoma as measured by leucocyte migration inhibition test. Urology 12: 525

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, 545, Osaka, Japan

    Shinichi Ikemoto, Seiji Wada, Masato Kamizuru, Nobuyuki Hayahara, Taketoshi Kishimoto & Masanobu Maekawa

Authors
  1. Shinichi Ikemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seiji Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masato Kamizuru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nobuyuki Hayahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Taketoshi Kishimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masanobu Maekawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikemoto, S., Wada, S., Kamizuru, M. et al. Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-γ production of lymphocytes. Cancer Immunol Immunother 34, 289–293 (1992). https://doi.org/10.1007/BF01741548

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741548

Key words

Search

Navigation